Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2025-12-25 @ 12:02 AM
NCT ID:
NCT00678158
Eligibility Criteria:
Inclusion Criteria:
* Biopsy-proven cancer verified at MSKCC
* Imaging evidence of lymph node metastases, bone metastases or soft tissue disease
* Age \> or = to 18 years
* KPS \> or = to 80
* Epidural disease is acceptable as long as the dose to the spinal cord ≤ 14 Gy
* Able to tolerate immobilization cradle positioning
Exclusion Criteria:
* Target lesion not visible on conventional CT scan
* Unable to be administered intravenous CT contrast safely
* Prior radiation to the planned target region. A second metastatic lesion would not be eligible if the area received or will receive any dose (5% or greater isodose line)from a prior or planned single fraction treatment
* Patients receiving concurrent chemotherapy (within 1 week of RT)
* Normal tissue directly overlying target precluding ability to limit the bowel, bladder, rectum or other tissue to 15-16 Gy dose constraints
* Weight-bearing bones with significant cortical destruction from tumor. In these cases, patients will be referred for orthopedic consultation for rod stabilization procedures.
* Subjects with more than 4 metastases to bone
* Any metastatic lesion larger than 8 cm in its greatest diameter
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00678158
Study Brief:
Protocol Section:
NCT00678158